GlassScriptPhysician profile
Jose S Soza
NPI 1427242866
$3,133.83
in general payments reported to CMS, 2019-2025
32 companies · $1,381 in 2025
The $1,381 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $223 · 2021: $94.81 · 2022: $161 · 2023: $268 · 2024: $867 · 2025: $1,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,515.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $481.42 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $407.16 | 2023-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $321.81 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $176.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $170.28 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $147.85 | 2020-2025 | Shingrix, Arexvy |
| Corcept Therapeutics | $140.24 | 2024-2025 | Korlym |
| Beta Bionics, INC. | $127.81 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbott Laboratories | $125.79 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $124.23 | 2019-2024 | |
| Baxter Healthcare | $112.80 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $95.78 | 2019-2024 | Farxiga |
| Dexcom, INC. | $90.36 | 2024-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $61.91 | 2025 | |
| Zimmer Biomet Holdings, INC. | $58.99 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $58.18 | 2025 | Inspire |
| Sumitomo Pharma America, INC. | $48.60 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $38.90 | 2025 | Gardasil 9, Capvaxive |
| Novartis Pharmaceuticals Corporation | $37.96 | 2025 | |
| Idorsia Pharmaceuticals US INC | $32.95 | 2023 | Quviviq |
| Amarin Pharma, INC. | $31.10 | 2019 | |
| Averitas Pharma INC. | $29.73 | 2023 | Qutenza |
| Cleerly, INC. | $28.41 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Kyowa Kirin, INC. | $27.86 | 2024 | Crysvita |
| Ethicon US, LLC | $24.03 | 2019 | |
| Hologic Sales and Service, LLC | $22.86 | 2025 | Aptima, Thinprep 2000 Processor |
| Sanofi Pasteur INC. | $21.76 | 2020 | |
| Mannkind Corporation | $20.43 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.48 | 2022 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Rgh Enterprises LLC | $17.33 | 2024 | |
| Abbvie INC. | $14.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Soza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.